These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 16184589
1. Hypereosinophilic syndrome: an update. Wilkins HJ, Crane MM, Copeland K, Williams WV. Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589 [Abstract] [Full Text] [Related]
2. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab. Schwartz LB, Sheikh J, Singh A. Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230 [Abstract] [Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec 11; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
12. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes. Helbig G, Kyrcz-Krzemień S. Pol Arch Med Wewn; 2011 Dec 11; 121(1-2):44-52. PubMed ID: 21346698 [Abstract] [Full Text] [Related]
13. Oral mucosa lesions in hypereosinophilic syndrome--an update. Ionescu MA, Murata H, Janin A. Oral Dis; 2008 Mar 11; 14(2):115-22. PubMed ID: 18194138 [Abstract] [Full Text] [Related]
14. Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis. Williams AK, Dou C, Chen LYC. Br J Haematol; 2021 Dec 11; 195(5):669-680. PubMed ID: 34105142 [Abstract] [Full Text] [Related]
15. Hypereosinophilic syndrome: case presentation and update. Leiferman KM, Gleich GJ. J Allergy Clin Immunol; 2004 Jan 11; 113(1):50-8. PubMed ID: 14713907 [Abstract] [Full Text] [Related]
16. The hypereosinophilic syndromes: still more heterogeneity. Gleich GJ, Leiferman KM. Curr Opin Immunol; 2005 Dec 11; 17(6):679-84. PubMed ID: 16214314 [Abstract] [Full Text] [Related]
17. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. Busse WW, Ring J, Huss-Marp J, Kahn JE. J Allergy Clin Immunol; 2010 Apr 11; 125(4):803-13. PubMed ID: 20371394 [Abstract] [Full Text] [Related]
18. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis. Lee CH, Mamelak AJ, Vonderheid EC. Int J Dermatol; 2007 Nov 11; 46(11):1198-204. PubMed ID: 17988344 [Abstract] [Full Text] [Related]
19. Biologic Agents for the Treatment of Hypereosinophilic Syndromes. Kuang FL, Klion AD. J Allergy Clin Immunol Pract; 2017 Nov 11; 5(6):1502-1509. PubMed ID: 29122152 [Abstract] [Full Text] [Related]
20. [The hypereosinophilic syndrome]. Jegou J, Barete S, Frances C. Ann Dermatol Venereol; 2003 Nov 11; 130(6-7):664-6. PubMed ID: 13679710 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]